Related Experiment Video
Updated: Oct 8, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Downregulation of the cdc2/cyclin B protein kinase activity by binding of p53 to p34(cdc2)
M Ababneh1, C Götz, M Montenarh
1Medizinische Biochemie und Molekularbiologie, Universität des Saarlandes, Gebäude 44, Homburg, 66421, Germany.
Abstract:
We previously found that p53 binds to the catalytic subunit of the p34(cdc2)/cyclin B1-kinase. In the present study we analyzed the functional consequences of this interaction. Binding of wild-type p53 to p34(cdc2)/cyclin B1 results in a significant decrease of its histone H1 kinase activity. Binding of p53 to the kinase is a prerequisite for the inhibition because a mutant p53 which lacks the binding region fails to influence the enzymatic activity. Furthermore, by using C-terminal fragments of p53 it became obvious that also some other structural elements in the N-terminal region are necessary for the inhibitory effect. Our present study provides evidence that p53 might regulate cell-cycle checkpoints not only on the transcriptional level but also by binding to the cell-cycle regulating kinase p34(cdc2).
Insights
The tumor suppressor protein p53 directly inhibits the cell-cycle kinase p34(cdc2)/cyclin B1. This interaction, crucial for cell-cycle regulation, involves specific binding regions on p53.
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Cancer Research
Background:
- The tumor suppressor protein p53 plays a critical role in maintaining genomic stability.
- Previous research established that p53 interacts with the p34(cdc2)/cyclin B1 kinase complex.
Purpose of the Study:
- To investigate the functional consequences of p53 binding to the p34(cdc2)/cyclin B1 kinase.
- To determine the role of p53 in regulating cell-cycle checkpoints beyond transcriptional control.
Main Methods:
- Biochemical assays to measure histone H1 kinase activity.
- Analysis of wild-type and mutant p53 binding to the p34(cdc2)/cyclin B1 complex.
- Use of C-terminal p53 fragments to identify necessary structural elements for inhibition.
Main Results:
- Wild-type p53 binding significantly reduces the histone H1 kinase activity of p34(cdc2)/cyclin B1.
- A p53 mutant lacking the binding region failed to inhibit kinase activity, confirming binding is essential.
- Specific N-terminal structural elements of p53 are also required for effective inhibition.
Conclusions:
- p53 directly regulates the enzymatic activity of the cell-cycle kinase p34(cdc2)/cyclin B1.
- This interaction suggests a novel, non-transcriptional mechanism for p53 in cell-cycle checkpoint control.
- p53 acts as a direct inhibitor of the p34(cdc2)/cyclin B1 kinase, impacting cell cycle progression.
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
Inhibition of CDK Activity
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle

